Cerus (CERS) Competitors $1.49 -0.07 (-4.49%) Closing price 04:00 PM EasternExtended Trading$1.50 +0.01 (+0.67%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CERS vs. STAA, OSUR, ANIK, UTMD, WST, COO, ALGN, MMSI, ICUI, and HAEShould you be buying Cerus stock or one of its competitors? The main competitors of Cerus include STAAR Surgical (STAA), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), Utah Medical Products (UTMD), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), and Haemonetics (HAE). These companies are all part of the "health care supplies" industry. Cerus vs. STAAR Surgical OraSure Technologies Anika Therapeutics Utah Medical Products West Pharmaceutical Services Cooper Companies Align Technology Merit Medical Systems ICU Medical Haemonetics STAAR Surgical (NASDAQ:STAA) and Cerus (NASDAQ:CERS) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their community ranking, earnings, analyst recommendations, valuation, risk, media sentiment, dividends, institutional ownership and profitability. Do insiders and institutionals believe in STAA or CERS? 96.7% of STAAR Surgical shares are held by institutional investors. Comparatively, 78.4% of Cerus shares are held by institutional investors. 1.0% of STAAR Surgical shares are held by insiders. Comparatively, 3.4% of Cerus shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is STAA or CERS more profitable? STAAR Surgical has a net margin of -6.44% compared to Cerus' net margin of -11.60%. STAAR Surgical's return on equity of -3.35% beat Cerus' return on equity.Company Net Margins Return on Equity Return on Assets STAAR Surgical-6.44% -3.35% -2.67% Cerus -11.60%-40.55%-11.12% Do analysts prefer STAA or CERS? STAAR Surgical presently has a consensus price target of $25.29, suggesting a potential upside of 44.82%. Cerus has a consensus price target of $4.00, suggesting a potential upside of 168.46%. Given Cerus' stronger consensus rating and higher probable upside, analysts plainly believe Cerus is more favorable than STAAR Surgical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score STAAR Surgical 1 Sell rating(s) 8 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Cerus 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility and risk, STAA or CERS? STAAR Surgical has a beta of 0.66, suggesting that its stock price is 34% less volatile than the S&P 500. Comparatively, Cerus has a beta of 1.56, suggesting that its stock price is 56% more volatile than the S&P 500. Does the MarketBeat Community prefer STAA or CERS? Cerus received 281 more outperform votes than STAAR Surgical when rated by MarketBeat users. Likewise, 72.34% of users gave Cerus an outperform vote while only 54.22% of users gave STAAR Surgical an outperform vote. CompanyUnderperformOutperformSTAAR SurgicalOutperform Votes28954.22% Underperform Votes24445.78% CerusOutperform Votes57072.34% Underperform Votes21827.66% Which has stronger valuation & earnings, STAA or CERS? STAAR Surgical has higher revenue and earnings than Cerus. STAAR Surgical is trading at a lower price-to-earnings ratio than Cerus, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSTAAR Surgical$313.90M2.74-$20.21M-$0.41-42.59Cerus$180.27M1.54-$37.49M-$0.11-13.55 Does the media refer more to STAA or CERS? In the previous week, STAAR Surgical had 15 more articles in the media than Cerus. MarketBeat recorded 18 mentions for STAAR Surgical and 3 mentions for Cerus. Cerus' average media sentiment score of 1.59 beat STAAR Surgical's score of 1.03 indicating that Cerus is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STAAR Surgical 8 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cerus 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive SummaryCerus beats STAAR Surgical on 10 of the 18 factors compared between the two stocks. Remove Ads Get Cerus News Delivered to You Automatically Sign up to receive the latest news and ratings for CERS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CERS vs. The Competition Export to ExcelMetricCerusSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$276.83M$4.46B$5.68B$8.32BDividend YieldN/A32.62%4.55%4.02%P/E Ratio-13.5528.9724.5519.25Price / Sales1.5450.15395.7294.09Price / CashN/A51.0838.1634.64Price / Book5.146.277.064.46Net Income-$37.49M$67.64M$3.19B$247.07M7 Day Performance4.20%9.90%1.49%3.05%1 Month Performance-8.59%-1.11%5.87%-2.85%1 Year Performance-14.86%24.89%14.94%4.63% Cerus Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CERSCerus2.2993 of 5 stars$1.49-4.5%$4.00+168.5%-16.1%$276.83M$180.27M-13.55290STAASTAAR Surgical4.4009 of 5 stars$17.62+3.3%$26.86+52.4%-51.9%$869.11M$313.90M-42.981,115OSUROraSure Technologies4.6569 of 5 stars$3.57+1.7%$5.50+54.1%-42.1%$267.04M$185.83M23.80840Buyback AnnouncementNews CoverageANIKAnika Therapeutics3.7396 of 5 stars$16.11+1.3%$22.00+36.6%-39.2%$235.95M$119.91M-2.42300UTMDUtah Medical Products3.5865 of 5 stars$57.93+1.1%N/A-16.8%$196.50M$40.90M14.67180News CoveragePositive NewsWSTWest Pharmaceutical Services4.5708 of 5 stars$231.60+0.6%$344.00+48.5%-41.1%$16.74B$2.89B34.6210,600COOCooper Companies3.2919 of 5 stars$79.91-1.6%$111.89+40.0%-16.3%$15.98B$3.93B40.9816,000Positive NewsHigh Trading VolumeALGNAlign Technology4.4617 of 5 stars$169.59+2.0%$269.91+59.2%-46.7%$12.48B$4.00B30.2321,610Analyst ForecastMMSIMerit Medical Systems3.4611 of 5 stars$100.69+1.8%$110.78+10.0%+44.8%$5.92B$1.36B49.366,950ICUIICU Medical4.4285 of 5 stars$149.21+4.0%$168.67+13.0%+52.7%$3.66B$2.38B-32.6514,000Positive NewsHAEHaemonetics4.6056 of 5 stars$64.84-1.0%$101.67+56.8%-19.6%$3.26B$1.37B25.533,657Positive News Remove Ads Related Companies and Tools Related Companies STAA Competitors OSUR Competitors ANIK Competitors UTMD Competitors WST Competitors COO Competitors ALGN Competitors MMSI Competitors ICUI Competitors HAE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CERS) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cerus Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cerus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CERS Stock Free CERS Stock Alerts